| Literature DB >> 24719802 |
Manouchehr Khoshbaten1, Hassan Soleimanpour2, Alireza Ala3, Samad Shams Vahdati3, Kimia Ebrahimian4, Saeid Safari5, Samad Ej Golzari6, Fariba Salek Ranjbarzadeh1, Robab Mehdizadeh Esfanjani7.
Abstract
BACKGROUND: Conventional educational systems seem to be improper throughout the cardiopulmonary resuscitation (CPR) teaching process. The most common causes of failed resuscitation are unfamiliarity with cardiopulmonary resuscitation algorithms, poor performance of leader of the CPR team and lack of skilled personnel, coordination among members during resuscitation, and responsibility of staff.Entities:
Keywords: Cardiopulmonary Resuscitation; Education; Emergency Medicine
Year: 2014 PMID: 24719802 PMCID: PMC3961037 DOI: 10.5812/aapm.15546
Source DB: PubMed Journal: Anesth Pain Med ISSN: 2228-7523
Advanced Cardiovascular Life Support Drug Questionnaire
|
|
| a. Vasopressin is indicated for VF and pulseless VT prior to the delivery of the first shock |
| b. The correct dose of Vasopressin is 40 U administered IV [ |
| c. Vasopressin is recommended instead of epinephrine for the treatment of asystole |
| d. Vasopressin can be administered twice during cardiac arrest |
|
|
| a. Amiodarone, lidocaine, epinephrine |
| b. Epinephrine, vasopressin, amiodarone |
| c. Lidocaine, epinephrine, vasopressin |
| d. Vasopressin, amiodarone, lidocaine |
|
|
| a. Magnesium is indicated for VF/pulseless VT associated with torsades de pointes |
| b. Magnesium is indicated for shock-refractory monomorphic VT |
| c. Magnesium is contraindicated in VT associated with a normal QT interval |
| d. Magnesium is indicated for VF refractory to shock and amiodarone or lidocaine. |
|
|
| a. Give an additional 2 mg of morphine sulfate |
| b. Start dopamine at 2 ụg/kg per minute and titrate to BP 100 systolic. |
| c. Give nitroglycerin 0.4 mg sublingually |
| d. Give normal saline 250 mL to 500 mL fluid bolus |
|
|
| a. Give lidocaine 1 - 1.5 mg IV bolus |
| b. Immediate synchronized cardioversion |
| c. Seek expert consultation |
| d. Give adenosine 6 mg IV bolus |
|
|
| a. Administer heparin if CT scan is negative for hemorrhage |
| b. Give aspirin 160 mg and clopidogrel 75 mg orally |
| c. Administer aspirin 160-325 mg orally chewed, immediately |
| d. Do not give aspirin for at least 24 hours if tPA is administered |
|
|
| a. External jugular vein |
| b. Femoral vein |
| c. Intraosseous |
| d. Endotracheal |
|
|
| a. Substitute clopidogrel 300 mg loading dose |
| b. Give aspirin 160 – 325 mg chewed, immediately |
| c. Give 75 mg enteric-coated aspirin only |
| d. Give 325 mg enteric-coated aspiring rectally |
|
|
| a. Atropine 0.5 mg |
| b. Atropine 1.0 mg |
| c. Atropine 0.1 mg |
| d. Atropine 3 mg |
|
|
| a. Atropine 1 mg |
| b. Epinephrine 1 mg |
| c. Vasopressin 20 U |
| d. Sodium bicarbonate 50 mEq |
|
|
| a. Epinephrine 2-10 ụg/kg per minute |
| b. Atropine 0.5 mg |
| c. Lidocaine 1 mg/kg |
| d. Adenosine 6 mg |
|
|
| a. HR of 90/min |
| b. BP > 180 systolic |
| c. Use of phosphodiesterase inhibitor within 12 hours |
| d. Left ventricular infarct with bilateral rales |
|
|
| a. give additional 1mg Atropine |
| b. Give NS bolus 250 mL-500mL |
| c. Start dopamine 10-20 ụg/kg per minute |
| d. Start epinephrine 2-10 ụg/min |
|
|
| a. Vasopressin 40U |
| b. Amiodarone 150 mg |
| c. Lidocaine 0.5 mg/kg |
| d. Epinephrine 3 mg |
| e. Amiodarone 300 mg |
|
|
| a. 0.5 - 0.75 mg/kg IV push |
| b. 2-3 mg/kg IV push |
| c. Give endotracheal dose 2-4 mg/kg |
| d. Start infusion 1 - 2 mg/min |
| e. 1 mg/kg IV push |
|
|
| a. place a Combitube or Laryngeal Mask Airway (LMA) |
| b. Attempt intubation with minimal CPR interruption |
| c. Call for a pulse check |
| d. Place IV or IO access |
|
|
| a. Vasopressin is indicated for VF and pulseless VT prior to the delivery of the first shock |
| b. Vasopressin can be administered twice during cardiac arrest |
| c. Vasopressin is recommended instead of epinephrine for the treatment of asystole |
| d. The correct dose of Vasopressin is 40 U administered IV or IO |
|
|
| a. Atropine 0.5 mg IV or IO |
| b. Epinephrine 3 mg via ETT |
| c. Dopamine 2 to 20 ụg/kg per minute IV or IO |
| d. Atropine 1 mg IV or IO |
| e. Epinephrine 1 mg or Vasopressin 40 U IV or IO |
|
|
| a. Obtain 12 lead ECG |
| b. Perform immediate synchronized cardioversion |
| c. Establish IV and give sedation for electrical cardioversion |
| d. Give amiodarone 300 mg IV push |
|
|
| a. Repeat the antiarrhythmic |
| b. Escalating dose epinephrine 3 mg |
| c. Second dose of epinephrine 1 mg |
| d. Sodium bicarbonate 50 mEq |
|
|
| a. HR is < 60 with or without symptoms |
| b. BP < 100 systolic without symptoms |
| c. The patient has an MI on the 12-lead ECG |
| d. CP or shortness of breath is present |
a Abbreviations: ACS, acute coronary syndrome; AED, automated external defibrillator; BP, blood pressure; CPR, cardiopulmonary resuscitation; CT, computed tomography; ER, emergency room; IO, intraosseous; IV, intravenous; MI, myocardial infarction; TCP, trans-cutaneous pacing; VFib, ventricular fibrillation; VTach, ventricular tachycardia.
The Effectiveness of Educational Methods on Knowledge of Cardiopulmonary Resuscitation Drugs in Groups I and II
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Electronic learning (Group I) | 1.4 ± 1.7 | 2.5 ± 1.0 | -0.7 | 0.14 | < 0.001 |
| Lecture-based education (Group II) | 1.7 ± 1.2 | 1.9 ± 1.2 | -0.089 | 0.13 | 0.49 |
|
| |||||
| Group I | 3.6 ± 1.9 | 5.3 ± 2.0 | -0.39 | 0.081 | < 0.001 |
| Group II | 3.9 ± 1.5 | 4.7 ± 2.05 | -0.46 | 0.096 | < 0.001 |
|
| |||||
| Group I | 2.4 ± 1.35 | 4.7 ± 1.6 | -0.668 | 0.088 | < 0.001 |
| Group II | 2.5 ± 1.3 | 4.1 ± 1.4 | -0.51 | 0.081 | < 0.001 |
|
| |||||
| Group I (frequency) | 15 ± 36 | 25 ± 61.0 | 0.996 | 0.353 | < 0.005 |
| Group II (frequency) | 21 ± 48 | 23 ± 53.5 | 0.186 | 0.37 | 0.62 |
a The data are expressed as mean ± SD, B reports Regression coefficient.
b Abbreviation: SE, standard error.
c Based on generalized estimating equations regression.